Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution-Reference-Cited by-同舟云学术

Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution

Published:2014-05-16 Issue:8 Volume:89 Page:813-818
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Tang Guilin¹,Zhang Liping¹,Fu Bin¹,Hu Jianhua²,Lu Xinyan¹,Hu Shimin¹,Patel Ankita³,Goswami Maitrayee¹,Khoury Joseph D.¹,Garcia-Manero Guillermo⁴,Medeiros L. Jeffrey¹,Wang Sa A.¹

Affiliation:

1. Department of Hematopathology; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston Texas

3. Department of Molecular and Human Genetics; Baylor College of Medicine; Houston Texas

4. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23751/fullpdf

Reference23 articles.

1. Prognostic features of chronic myelomonocytic leukaemia: A modified Bournemouth score gives the best prediction of survival;Worsley;Br J Haematol,1988

2. Two groups of chronic myelomonocytic leukaemia: Myelodysplastic and myeloproliferative. Prognostic implications in a series of a single center;Gonzalez-Medina;Leuk Res,2002

3. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: A retrospective analysis of 213 patients;Onida;Blood,2002

4. Risk assessment in chronic myelomonocytic leukemia (CMML);Germing;Leuk Lymphoma,2004

5. Cytogenetic risk stratification in chronic myelomonocytic leukemia;Such;Haematologica,2011

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in the Molecular Pathogenesis and Diagnosis of Chronic Myelomonocytic Leukemia;Advances in Molecular Pathology;2024-08

2. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30

3. Co-occurrence of High-Risk Myelodysplastic Syndrome With a Complex Karyotype/TP53 Mutation and IgG Lambda Monoclonal Gammopathy of Undetermined Significance;Cureus;2024-04-17

4. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management;American Journal of Hematology;2024-03-07

5. Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022;Blood Journal;2023-12-08